We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Multi-Site Closure System Simplifies Electrophysiology Procedures

By HospiMedica International staff writers
Posted on 15 Jan 2019
Print article
Image: The Vascade MVP system places a collagen patch on the outside of each blood vessel puncture site (Photo courtesy of Cardiva Medical).
Image: The Vascade MVP system places a collagen patch on the outside of each blood vessel puncture site (Photo courtesy of Cardiva Medical).
A new system uses resorbable collagen patches for multi-site vessel closure following electrophysiology procedures, such as cardiac ablation and left atrial appendage (LLA) closure.

The Cardiva Medical (Sunnyvale, CA, USA) Vascade MVP system is a fully integrated, extravascular system that combines collapsible disc technology and thrombogenic collagen hemostatic patches to accelerate coagulation at femoral artery access sites. The small, collapsible bi-convex low profile nitinol mesh disc is first placed against the inside of the vessel wall to temporarily stop the bleeding. A collagen patch is then released into the tissue tract, expanding approximately 13 times, and the mesh disc is then removed.

The expanded collagen ensures the residual tissue tract is sufficiently filled following completion of the electrophysiology procedure; nothing is left behind inside the vessel, and the collagen outside the vessel wall is rapidly resorbed, enabling future access procedures. Vascade MVP has been shown to reduce time to ambulation, total post-procedure time, time to hemostasis, and time to discharge eligibility in patients undergoing catheter-based procedures utilizing 6-12F inner diameter procedural sheaths, with single- or multiple-access sites in one or both limbs.

“The Vascade MVP system marks the culmination of a multi-year effort by Cardiva to pioneer the first dedicated vessel closure solution for electrophysiology procedures such as cardiac ablation and left atrial appendage closure,” said John Russell, CEO of Cardiva Medical. “We are proud to have partnered with leading EP physicians in the United States to address this unmet need, and enable patients to get back on their feet sooner and improve the workflow for these highly successful procedures.”

“With the Vascade MVP device, we have been able to get patients safely on their feet hours earlier than previously possible after an ablation for atrial fibrillation or a left atrial appendage closure procedure,” said Amin Al-Ahmad, MD, of the Texas Cardiac Arrhythmia Institute (Austin, USA). “In our practice the new Cardiva workflow has freed up staff and beds, and patient satisfaction has skyrocketed with less time spent immobilized on their backs. This new workflow may also make it possible to send more patients home the same day as their procedure.”

Since 1959, physicians have been using the Modified Seldinger Technique to insert flexible catheters into the femoral artery of patients to perform procedures in the arterial-vascular system. The most prevalent such procedure, diagnostic angiography, is thought to be performed more than 500,000 times per month worldwide. At the end of every such case, each patient is left with a substantial hole in the femoral artery, which typically takes significant effort and catheterization laboratory resources to close.

Related Links:
Cardiva Medical

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Vital Signs Monitor
M3/M3A

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.